跳至主要内容
临床试验/NCT06902285
NCT06902285招募中4 期

Use of Magnesium-L-Threonate to Improve Subjective Sleep Quality After Total Joint Arthroplasties: Randomized Controlled Clinical Trial

University of Miami2 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2025年4月21日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
招募中
入组人数
64
试验地点
2
主要终点
Change in Epsworth Sleepiness Score

研究概览

简要总结

The study team is conducting a study to see if Magnesium-L-Threonate (MgT) can help improve how well participants sleep and reduce pain after total joint replacement surgery

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing primary total knee or hip arthroplasty at the University of Miami Hospital
  • Patients > 18 years of age
  • Subjects must be capable of providing informed consent
  • English or Spanish-speaking

排除标准

  • Previous total joint arthroplasty at the surgical site
  • History of sleeping disorders, including narcolepsy, sleep apnea, insomnia, parasomnias, and restless leg syndrome.
  • History of Complex Regional Pain Syndrome in ipsilateral extremity
  • History of demyelinating disorder or neurologic deficit in the affected extremity
  • History of psychiatric disorders that could impact sleep, such as untreated depression, bipolar disorder, or schizophrenia.
  • Participants taking medications known to cause significant sedation or insomnia.
  • Pregnant or breastfeeding
  • Being treated for a diagnosis other than primary osteoarthritis (e.g. pelvic/femur fracture)
  • Patients with known substance use disorder within 6 months of surgery
  • Liver Failure, via clinical diagnosis or international normalized ratio greater than 1.5 or Prothrombin time greater than 40
  • Chronic Kidney Disease or glomerular filtration rate less than 30 mL/min

研究组 & 干预措施

Magnesium L Threonate Group

Experimental

Participants in this group will receive the Magnesium L Threonate intervention for up to 6 weeks postoperatively

干预措施: Magnesium Threonate (Drug)

Control Group

Placebo Comparator

Participants in this group will receive the placebo comparator for up to 6 weeks postoperatively

干预措施: Control (Other)

结局指标

主要结局

Change in Epsworth Sleepiness Score

时间窗: 2 weeks, 4 weeks, 6 weeks

Score ranging from 0-24 with higher scores indicating greater sleepiness.

Change in Pittsburgh Sleep Quality Index (PSQI)

时间窗: 2 weeks, 4 weeks, 6 weeks

The total score has a value between 0-21 and a high total score demonstrates a poor quality of sleep. A total PSQI score which is ≤5 indicates "good sleep", and a score which is \>5 indicates "poor sleep

次要结局

  • Change in Morphine Milligram Equivalent Prescribed(2 weeks, 4 weeks, 6 weeks)
  • Patient-reported outcome measured by Knee Injury and Osteoarthritis Outcome Score(6 weeks)
  • Medication Compliance measured in number of days study medication taken(6 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Victor Hugo Hernandez

Professor

University of Miami

研究点 (2)

Loading locations...

相似试验

Magnesium-L-Threonate for Sleep Quality... | 临床试验